Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) EBIT Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -3.76%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.39%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 7.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 34.83%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 75.54%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -24.91%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn 75.87%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 75.87%
Sep 30, 2025 49.44%
Jun 30, 2025 77.12%
Mar 31, 2025 37.16%
Dec 31, 2024 77.01%
Sep 30, 2024 -37.75%
Jun 30, 2024 -81.71%
Mar 31, 2024 -785.36%
Dec 31, 2023 -108.15%
Sep 30, 2023 -86.18%
Jun 30, 2023 -53.18%
Mar 31, 2023 -4.96%
Dec 31, 2022 130.61%
Sep 30, 2022 -39.16%
Jun 30, 2022 -32.17%
Mar 31, 2022 -39.95%
Dec 31, 2021 41.11%
Sep 30, 2021 -0.23%
Jun 30, 2021 39.89%
Mar 31, 2021 85.55%
Dec 31, 2020 74.08%
Sep 30, 2020 29.31%
Jun 30, 2020 60.65%
Mar 31, 2020 19.02%
Dec 31, 2019 34.98%
Sep 30, 2019 28.19%
Jun 30, 2019 35.75%
Mar 31, 2019 34.37%
Dec 31, 2018 -31.91%
Sep 30, 2018 33.52%
Jun 30, 2018 -17.80%
Mar 31, 2018 1.48%
Dec 31, 2017 -113.52%
Sep 30, 2017 -55.32%
Jun 30, 2017 -68.31%
Mar 31, 2017 -29.14%
Dec 31, 2016 31.25%
Sep 30, 2016 6.75%
Jun 30, 2016 -4.37%
Mar 31, 2016 -24.19%
Dec 31, 2015 -4.86%
Sep 30, 2015 -192.26%
Jun 30, 2015 -58.51%
Mar 31, 2015 -10.82%
Dec 31, 2014 2.28%
Sep 30, 2014 7.22%
Jun 30, 2014 -68.18%
Mar 31, 2014 14.93%
Dec 31, 2013 3.96%
Sep 30, 2013 -4.03%
Jun 30, 2013 -13.49%